ArticleFrontiers in pharmacology2023
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Can G Leineweber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it